3. Although rFVIIa can limit the extent of hematomaexpansion in noncoagulopathic ICH patients, thereRecommendations1. Patients with a severe coagulation factor deficiency orsevere thrombocytopenia should receive appropriate factorreplacement therapy or platelets, respectively (Class I;Level of Evidence: C)....